Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal

Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal Professional audiences…


Obesity Weekly News

Obesity Video Recap—December 9, 2025

This biweekly obesity video recap covers major GLP-1 therapeutic advances,…


Obesity Weekly News

Obesity Video Recap—November 25, 2025

This biweekly obesity video recap covers late-stage obesity trial readouts,…


Obesity Weekly News

Obesity Video Recap—November 11, 2025

This biweekly obesity video recap reviews major moves shaping the obesity and…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera

Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…


Obesity Weekly News

Obesity Today — October 28, 2025

Catch the latest obesity news, featuring industry updates, clinical progress,…


Obesity Weekly News

Obesity Video Recap — October 28, 2025

Join us for this biweekly roundup of obesity news, where we summarize important…


Obesity Weekly News

Obesity Today—October 21, 2025

Stay updated with this week’s obesity news, covering key developments and…


Endocrinology

Endocrinology Video Recap — October 21, 2025

In this video, we take a closer look at the newest updates in Endocrinology.…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Kailera Therapeutics $600m Series B

Lucid Diligence Brief: Kailera Therapeutics $600m Series B Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion

Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to…


EASD 2025 Preview: Key Diabetes Highlihts to Watch

EASD 2025 at a glance In the lead-up to EASD 2025, LucidQuest spotlights…


Privacy Preference Center